Malignant middle cerebral artery infarction: a clinical study of 32 patients

Adrià Arboix1, Luís García-Eroles2, Montserrat Oliveres1

  • 1Cerebrovascular Division, Neurology Department, Hospital Universitari del Sagrat Cor, Universitat de Barcelona, Barcelona, Catalonia, Spain.

Abstract

Insights

Malignant middle cerebral artery infarction is a severe stroke with poor outcomes. Key predictors include decreased consciousness, nausea/vomiting, and heavy smoking, aiding early identification and prognosis.

Area of Science:

  • Neurology
  • Stroke Medicine
  • Clinical Prognosis

Background:

  • Malignant middle cerebral artery infarction (MMCAI) is a severe stroke subtype with high mortality.
  • Clinical predictors for MMCAI are not well-established, necessitating further research.

Purpose of the Study:

  • To identify clinical prognostic factors associated with MMCAI.
  • To enhance understanding of MMCAI development and patient outcomes.

Main Methods:

  • Analysis of 32 MMCAI patients from a stroke registry of 1,396 ischemic stroke cases.
  • Logistic regression analysis to determine independent predictive value of variables.

Main Results:

  • MMCAI patients had a mean age of 74.7 years, with 50% males.
  • 25% experienced in-hospital death; 50% had poor early prognosis.
  • Decreased consciousness (OR: 4.17), nausea/vomiting (OR: 3.65), and heavy smoking (OR: 2.62) were independent predictors.

Conclusions:

  • MMCAI is an infrequent but serious condition with high mortality.
  • Decreased consciousness, nausea/vomiting, and heavy smoking are significant clinical predictors of MMCAI.

Related Concept Videos